Skip to main content
Fig. 3 | Hereditas

Fig. 3

From: A novel chromatin regulator-related immune checkpoint related gene prognostic signature and potential candidate drugs for endometrial cancer patients

Fig. 3

The development of a gene signature to predict patients OS. A, B Lasso-Cox regression analysis; C Risk scores of UCEC patients; D Survival status of UCEC patients; E Kaplan–Meier survival analysis of patients between high- and low-risk groups; F The 1-, 3- and 5-year ROC curve to predict the survival status; G Heatmap showed the differences of 9 genes based on riskscore

Back to article page

Hereditas

ISSN: 1601-5223

Contact us